Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Urica
- Development stage
- Unknown
- Lead developer
- Riddhi Healthcare
- Administration
- Oral
01
Overview
Urica is an Ayurvedic herbal supplement manufactured by Riddhi Healthcare, intended for the management of high uric acid levels (hyperuricemia) and associated joint conditions such as gout. As a polyherbal formulation, it typically incorporates traditional Indian medicinal plants known for their anti-inflammatory and diuretic properties to support joint health and metabolic balance. The product is marketed as a natural alternative for individuals seeking to maintain healthy uric acid levels and is available in tablet form. It is not a clinical-stage pharmaceutical drug and does not have associated phase-based trial data or a specific molecular target in the Western pharmacological sense.
- Brand names
- Urica
- Other names
- Urica Tablet
Beyond the preview
Go deeper on Urica.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Urica.